"The US Food and Drug Administration (FDA) has approved the tumor necrosis factor inhibitor adalimumab (Humira, AbbVie) for the treatment of moderate to severe hidradenitis suppurativa (HS), making it the first and only FDA-approved therapy"...
Clobevate (clobetasol propionate gel) is a super-high potency corticosteroid formulation indicated for the relief of the inflammatory and pruritic manifestations of corticosteroid-responsive dermatoses.
Treatment beyond 2 consecutive weeks is not recommended, and the total dosage should not exceed 50 g per week because of the potential for the drug to suppress the hypothalamic-pituitary-adrenal (HPA) axis. Use in children under 12 years of age is not recommended.
DOSAGE AND ADMINISTRATION
Apply a thin layer of Clobevate (clobetasol propionate gel) to the affected areas twice daily and rub in gently and completely (see INDICATIONS AND USAGE).
Clobevate (clobetasol propionate gel) is a super-high potency topical corticosteroid; therefore, treatment should be limited to 2 consecutive weeks, and amounts greater than 50 g per week should not be used.
Clobevate (clobetasol propionate gel) should not be used with occlusive dressings.
Clobevate® (Clobetasol Propionate Gel) 0.05% is supplied in 45-g (NDC 0145-2790-04) tubes.
Store between 15° and 30°C (59° and 86°F). Clobevate (clobetasol propionate gel) should not be refrigerated.
Stiefel Laboratories, Inc. Coral Gables, FL 33134. Rev. 0804This monograph has been modified to include the generic and brand name in many instances.
Last reviewed on RxList: 5/5/2009
Additional Clobevate Information
Report Problems to the Food and Drug Administration
You are encouraged to report negative side effects of prescription drugs to the FDA. Visit the FDA MedWatch website or call 1-800-FDA-1088.
Find out what women really need.